These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
15. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial. Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators. Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853 [Abstract] [Full Text] [Related]
16. Clopidogrel desensitization protocol for the treatment of thienopyridine hypersensitivity. Walker NE, Fasano MB, Hobbs RA, Horwitz PA. Crit Pathw Cardiol; 2007 Mar 10; 6(1):26-9. PubMed ID: 17667884 [Abstract] [Full Text] [Related]
18. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel. Prescrire Int; 2009 Oct 10; 18(103):193-5. PubMed ID: 19877380 [Abstract] [Full Text] [Related]
19. Clopidogrel hypersensitivity: a novel multi-day outpatient oral desensitization regimen. Fajt M, Petrov A. Ann Pharmacother; 2010 Jan 10; 44(1):11-8. PubMed ID: 20009004 [Abstract] [Full Text] [Related]